MBRX icon

Moleculin Biotech
MBRX

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $8.88M invested in Moleculin Biotech in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.93M
2
+$1.51M
3
+$947K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$513K
5
Northern Trust
Northern Trust
Illinois
+$146K

Top Sellers

1
-$756K
2
-$105K
3
-$29K
4
HighTower Advisors
HighTower Advisors
Illinois
-$21K
5
LWMG
Levy Wealth Management Group
Pennsylvania
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
27
$1K
28
$1K
29
$1K
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
1
2